General Information of the Compound
Compound ID
CP0523082
Compound Name
4-nitro-N-(1,4-diphenyl-1H-pyrazol-5-yl)benzamide
    Show/Hide
Synonyms
VU-71
VU71
    Show/Hide
Structure
Formula
C22H16N4O3
Molecular Weight
384.395
Canonical SMILES
[O-][N+](=O)c1ccc(cc1)C(=O)Nc1c(cnn1-c1ccccc1)-c1ccccc1
    Show/Hide
InChI
InChI=1S/C22H16N4O3/c27-22(17-11-13-19(14-12-17)26(28)29)24-21-20(16-7-3-1-4-8-16)15-23-25(21)18-9-5-2-6-10-18/h1-15H,(H,24,27)
    Show/Hide
InChIKey
UCQCMSNDKYLLFD-UHFFFAOYSA-N
Physicochemical Property
logP
4.6998
Rotatable Bonds
5
Heavy Atom Count
29
Polar Areas
90.06
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11523834
SID: 16625817
ChEMBL ID
CHEMBL377636
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01247, Metabotropic glutamate receptor 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( VU-71 )
Drug Name VU-71
Target(s)
Metabotropic glutamate receptor 1 (mGluR1)
Modulator (allosteric modulator)